Characterization of a Novel Interaction between Bcl-2 Members Diva and Harakiri by Sborgi, Lorenzo et al.
Characterization of a Novel Interaction between Bcl-2
Members Diva and Harakiri
Lorenzo Sborgi, Susana Barrera-Vilarmau, Patricia Obrego´n, Eva de Alba*
Centro de Investigaciones Biolo´gicas, Consejo Superior de Investigaciones Cientı´ficas, Madrid, Spain
Abstract
Interactions within proteins of the Bcl-2 family are key in the regulation of apoptosis. The death-inducing members control
apoptotic mechanisms partly by antagonizing the prosurvival proteins through heterodimer formation. Structural and
biophysical studies on these complexes are providing important clues to understand their function. To help improve our
knowledge on protein-protein interactions within the Bcl-2 family we have studied the binding between two of its
members: mouse Diva and human Harakiri. Diva has been shown to perform both prosurvival and killing activity. In
contrast, Harakiri induces cell death by interacting with antiapoptotic Bcl-2 members. Here we show using ELISA and NMR
that Diva and Harakiri can interact in vitro. Combining the NMR data with the previously reported three-dimensional
structure of Diva we find that Harakiri binds to a specific region in Diva. This interacting surface is equivalent to the known
binding area of prosurvival Bcl-2 members from the reported structures of the complexes, suggesting that Diva could
function at the structural level similarly to the antiapoptotic proteins of the Bcl-2 family. We illustrate this result by building
a structural model of the heterodimer using molecular docking and the NMR data as restraints. Moreover, combining
circular dichroism and NMR we also show that Harakiri is largely unstructured with residual (13%) a-helical conformation.
This result agrees with intrinsic disorder previously observed in other Bcl-2 members. In addition, Harakiri constructs of
different length were studied to identify the region critical for the interaction. Differential affinity for Diva of these
constructs suggests that the amino acid sequence flanking the interacting region could play an important role in binding.
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Introduction
Programmed cell suicide known as apoptosis controls cell
homeostasis and is thus central to the life cycle of multi-cellular
organisms [1]. Proteins of the Bcl-2 family are key regulators of
apoptotic mechanisms by mediating in an intricate network of
interactions between pro- and antiapoptotic members that
eventually lead to the activation of caspases, the true apoptosis
executors [2–3]. Bcl-2 proteins share low sequence homology in
small stretches of amino acids named Bcl-2 homology (BH)
domains. Members that promote cell survival (e.g. Bcl-2, Bcl-XL,
Bcl-w, Mcl-1, BFL-1) contain four BH domains (BH1-BH4),
whereas members with killing activity can share homology either
in three BH domains or solely in the BH3 region (the BH3-only
subfamily). As a response to death stimuli, BH3-only proteins form
heterodimers with prosurvival members, thus antagonizing their
function [4–7]. Reported evidence indicates that peptides of ,16–
25 amino acids comprising the BH3 domain of BH3-only proteins
suffice for heterodimer formation [8]. Therefore, most of the
structural information currently known on BH3-only proteins is
centered at BH3 peptides. All known three-dimensional (3D)
structures of complexes between prosurvival Bcl-2 members and
these peptides show that the latter adopt a-helical structure and
are located in a hydrophobic groove of the prosurvival protein
surface [8–9]. However, BH3 peptides have been shown to behave
like random coils in isolation [9], and experimental evidence
together with prediction programs support that several BH3-only
proteins are intrinsically disordered [10]. Thus, it has been
suggested that additional energetic factors besides specific
intermolecular interactions likely play a role in this peculiar
binding process [9].
The dysfunction of apoptotic mechanisms has been pointed as a
hallmark of cancer. In particular, tumor cells overexpress
prosurvival Bcl-2 members and tumor suppressor p53 fails at
activating several BH3-only proteins conferring death resistance to
cancer cells [11]. These findings have both increased interest in
the use of BH3-only proteins as scaffolds for drug design [12–14]
and targeted research at the detailed understanding of Bcl-2
interactions. Recent work in this direction has shown that
antiapoptotic Bcl-2 members can bind preferentially particular
subsets of BH3-only proteins [15–17]. This selectivity has been
related to differential apoptotic response [16,17]. However, the
conclusions derived from these studies are at variance likely
because of the complexity of the molecular mechanisms involved
as well as the need to compare in vitro and in vivo data. Additional
work is thus necessary to fully understand Bcl-2 interactions and
their relation to programmed cell death. To gain insight into the
structural and biophysical factors involved in Bcl-2 protein-protein
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binding, we report here the characterization of a novel interaction
between the BH3-only protein Harakiri and the Bcl-2 member
Diva (also called Boo).
Harakiri localizes in membranes and exerts proapoptotic
activity by interacting with survival Bcl-XL and Bcl-2 [18].
Harakiri has not been characterized at the structural level except
for its C-terminal sequence (,30 amino acids), which is known
from low-resolution techniques to adopt a-helical conformation
in model membranes [19]. Diva has also been found predom-
inantly in membranes [20–21]. However, little functional data on
Diva is available. Specifically, previous independent reports
indicate that Diva can have both pro- or antiapoptotic function
[20–21]. Diva has also been reported to bind antiapoptotic Bcl-
XL, and the proapoptotic Bcl-2 members Bik and Bak, according
to co-immunoprecipitation assays [21]. In contrast, binding
studies using isothermal titration calorimetry indicate that Diva
does not bind peptides comprising the BH3 region of several
proapoptotic Bcl-2 proteins, including Bak and Harakiri [22]. On
this basis it has been suggested that Diva is not functionally
equivalent to other Bcl-2 proteins [22]. However, the 3D
structure of Diva is very similar to the known structures of other
Bcl-2 members [22].
Here we show using ELISA and NMR that Diva and Harakiri
can interact in vitro. Our NMR data combined with the recently
reported structure of Diva [22] indicate that the interaction
involves in Diva’s surface the same groove previously observed in
all other known structures of antiapoptotic/BH3-peptide com-
plexes, indicating that binding is specific. To illustrate the
formation of the complex a 3D structural model of the
heterodimer is built using molecular docking and the NMR data
as restraints. Altogether, these results suggest that at the structural
level Diva binds death-inducing Harakiri in a fashion similar to
other antiapoptotic Bcl-2 proteins. In addition, structural studies
on Harakiri were carried out using NMR and circular dichroism.
The data show that Harakiri is largely unstructured with only a
small population of residual a-helical conformation. This result
indicates that Harakiri is an intrinsically disordered protein like
several other members of the BH3-only subfamily [10]. As BH3-
derived peptides in isolation show little structure [9] whereas they
form a helix when bound to the prosurvival protein, it is plausible
that structure formation in the peptide is connected to binding
[9,10]. Thus, using NMR titration experiments we estimated an
apparent dissociation constant of the complex assuming a simple
model that takes into account Harakiri folding upon binding. In
addition, by studying the binding to Diva of Harakiri constructs of
different length we identify the critical region for binding in
Harakiri and observe that affinity increases for constructs longer
than this region, suggesting that the flanking sequence can
influence binding.
Results
Interaction between Diva and Harakiri detected by ELISA
The interaction between Harakiri and Diva was studied using
three Harakiri constructs of different length all including the BH3
region (Fig. 1A): the entire cytosolic domain of Harakiri
encompassing residues 1 to 59 (Hrk_DTM) [18], a 32 residue-
long peptide comprising the BH3 domain flanked by two segments
predicted to have a-helical propensity according to the program
PredictProtein [23] (Hrk_medium), and a 16 amino acid-long
peptide spanning the BH3 domain alone (Hrk_BH3).
ELISA was used to test the binding capabilities of the three
constructs to Diva. Hrk_DTM and Hrk_medium show significant
levels of interaction, with the entire cytosolic domain displaying
higher binding affinity (Fig. 1B). Interaction levels typically
decrease with peptide concentration as expected (Fig. 1B). In
contrast, protein-binding levels are negligible for the shortest
fragment Hrk_BH3 and do not show any dependence with
peptide concentration, suggesting that the observed residual signal
corresponds to background levels (Fig. 1B). Altogether, ELISA
data indicate that the length of the Harakiri constructs has a
significant effect on binding to Diva.
NMR characterization of Diva/Harakiri interaction
We further studied the interaction between Diva and Harakiri
by NMR, as this is the technique of choice to identify at the atomic
level structural changes associated to protein interactions [24].
Amide [1H,15N]-HSQC experiments [25] of 15N-labeled Diva
were recorded upon the addition of unlabeled Hrk_DTM.
Significant changes in NMR signals were observed, thus
confirming the interaction (Fig. 2A). Chemical shift assignments
of the backbone amide 1H and 15N resonances were obtained for
each titration point (Fig. 2B). Residues with the largest chemical
shift perturbations (.0.1 ppm) are mainly located in the regions
44–67, 74–78, 85–98 and 155–160 (Fig. 2C) indicating their
participation in the binding interface. According to the secondary
structure of Diva [26] these residues belong to helices 2, 3, 4, 5 and
8 (Fig. 2C). In addition, the mapping of the chemical shift
perturbation data on the 3D structure of Diva [22] reveals that the
binding region is equivalent to that observed in all known 3D
structures of complexes between antiapoptotic Bcl-2 members and
BH3-derived peptides [8,9,27,28]. This result is illustrated in
Figure 3 using as examples the 3D structures of the complexes
human Mcl-1/Bid_BH3 peptide [28] and mouse Bcl-XL/
Bad_BH3 peptide (pdb ID 2BZW) (Fig. 3B,C). The 3D structure
of human Mcl-1/Bid_BH3 peptide was selected because Mcl-1 is
the closest structural analogue to Diva according to the Dali server
[29] and the peptide is the longest reported up to date for these
complexes (35 residues), thus more similar to the Diva/Hrk_DTM
interaction. In addition, the structure of mouse Bcl-XL/Bad_BH3
peptide complex was included to help illustrate that heterodimers
of human and mouse species are equivalent at the structural level
(Fig. 3). The interaction between prosurvival Bcl-2 members and
BH3-only proteins is specific in that binding always involves the
BH3 domain of the BH3-only protein and helices 2, 3, 4, 5 and 8
of the prosurvival partner. According to the chemical shift
perturbation data the Diva/Hrk_DTM interaction shares the
same type of specificity as illustrated in the sequence alignments
shown in Figure 3D&E.
The interaction of Diva with the shorter fragments Hrk_me-
dium and Hrk_BH3 was also studied by NMR. For the shortest
fragment Hrk_BH3, no chemical shift changes in the [1H,15N]-
HSQC spectrum of Diva were observed even at a Diva/Hrk_BH3
,1:15 molar ratio (Diva at 0.1 mM and Hrk_BH3 at 1.5 mM)
(data not shown), suggesting the absence of the interaction. In
contrast, Diva’s NMR spectrum varies upon the addition of
Hrk_medium (Fig. 4). The spectrum of a mixture of Diva and
Hrk_medium at ,1:10 molar ratio (Diva 0.1 mM and Hrk_me-
dium 1 mM) shows changes almost identical to those observed for
the binding to Hrk_DTM at ,1:2 molar ratio (Diva 0.18 mM,
Hrk_DTM 0.37 mM) (Fig. 2C, lower panel). Therefore, there is
very good agreement between the NMR and ELISA results on
weaker binding observed for Hrk_medium relative to the entire
cytosolic domain, and negligible binding for Hrk_BH3 (Fig. 1B).
Moreover, the identical NMR spectra obtained for Diva/
Hrk_DTM and Diva/Hrk_medium mixtures (Fig. 2C, lower
panel) indicate that the binding interface of both complexes is
analogous.
Interaction between Diva and Harakiri
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Hrk_DTM is largely disordered and shows residual
a-helical structure
Circular dichroism (CD) experiments were performed on
Harakiri’s cytosolic domain to obtain information on its conforma-
tional behavior. The CD data indicate that Hrk_DTM adopts a-
helical structure with ,13% population in aqueous milieu that
increases to ,35% in the presence of the secondary structure
enhancer trifluoroethanol (Fig. 5). Thus, the cytosolic domain of
Harakiri is largely unstructured. Consequently, the NMR spectra of
Hrk_DTM show small amide 1H chemical shift dispersion (from
,7.9 to 8.7 ppm) and severe signal overlap (Fig. 6). These spectral
features together with the absence of methyl signals at ,0 ppm are
characteristic of disordered proteins, in agreement with the CD
data. Similar conformational behavior has been observed for BH3-
derived peptides [9] and other members of the BH3-only subfamily
[10]. For instance, the BH3-only proteins Bim, Bad, and Bmf have
been found to be unstructured. In particular, Bim undergoes partial
folding upon binding to Bcl-2 members [10]. The relation between
function and disorder is a distinctive feature of natively unfolded
proteins [30], thus several BH3-only members have been suggested
Figure 1. Harakiri constructs and ELISA binding. (A) One-letter code amino acid sequence of human Harakiri and constructs studied. The BH3
region, the transmembrane domain and the predicted a-helical segments are indicated. (B) Difference in ELISA absorbance relative to the control for
the binding of Diva to Hrk_DTM, Hrk_medium and Hrk_BH3 vs. fragment concentration. Shown values are average of two measurements. Thin bars
represent the standard deviation. The absorbance value for the control is 0.1260.01.
doi:10.1371/journal.pone.0015575.g001
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Figure 2. Interaction between Diva and Harakiri by NMR. (A) [1H-15N]-HSQC spectra of 15N,13C-labeled Diva (black), and Diva (0.12 mM) in the
presence of unlabeled Hrk_DTM (0.85 mM) (red). Several residues undergoing large perturbations are indicated. The asterisk indicates a folded peak.
Trp side chains are labeled as ‘‘s.c.’’. (B) Superposition of regions of Diva [1H-15N]-HSQC spectra resulting from the titration with Hrk_DTM. Residues
Interaction between Diva and Harakiri
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to be intrinsically disordered [10]. Moreover, coupled folding and
binding, a mechanism shown to be followed by some natively
unfolded proteins [31], has been proposed for BH3-only proteins
that are disordered in the unbound state and adopt helical structure
when complexed [10]. The residual a-helical structure and
sensitivity to trifluoroethanol of Hrk_DTM indicate its propensity
to fold as a helix, thus suggesting a connection between folding and
binding to Diva. The observed changes in the signals of the NMR
spectrum of Hrk_DTM upon the interaction (Fig. 6) are small
because chemical shifts are averaged by the populations of the
bound and unbound forms, and the latter predominates under the
conditions used (0.85 mM Hrk_DTM and 0. 12 mM Diva). The
upper limits for the bound and unbound forms are 0.12 mM and
0.73 mM, respectively. The observed chemical shift changes could
result from both the formation of the helix and the interaction itself.
However, further analysis of the spectra is significantly complicated
by the small chemical shift dispersion and signal overlap (Fig. 6).
Structural model of Diva/Harakiri heterodimer
To illustrate the interaction between Diva and Harakiri we built a
model of the complex using molecular docking and the chemical
shift perturbation data (Fig. 2C). In the 3D structures of all known
heterodimers the BH3-peptide forms a helix [8,9,28]. Therefore,
based on the residual a-helical structure of the entire cytosolic
domain of Harakiri, a 3D model of the helix was obtained using a
protein structure prediction program and the structure of the helix
formed by a BH3-peptide bound to a Bcl-2 member as template
(Materials and Methods). It is noteworthy that the modeled helix
spans residues 23 to 59, which includes the BH3 region and the
predicted helices (Fig. 1A), leaving the N-terminal 22 residues with
no regular secondary structure. This 3D model together with the
reported structure of Diva [22] were used in the molecular docking
protocol, which also included information from the NMR data on
the interacting surface in Diva as experimental restraints (Materials
and Methods). The complexity of Harakiri NMR spectra precludes
the identification of residues directly involved in the interaction, and
thus residues 22–53 (Hrk_medium), which are known to be critical
for binding from the NMR and ELISA data, were all input as
participating residues in the docking protocol. The resulting 3D
model of the heterodimer shows a binding cleft formed by helices 2–
5 and 8 that is occupied by the modeled a-helical cytosolic domain
of Harakiri (Fig. 7A). This cleft is topologically similar to all other
known heterodimers of the family (examples are shown in
Fig. 7B,C), which suggests that Diva is capable of interacting at
the structural level like other antiapoptotic Bcl-2 members.
The structural model of the Diva/Harakiri heterodimer also
explains the almost identical chemical shift perturbation data
obtained for the binding of Diva to Hrk_DTM and Hrk_medium
(Fig. 2C, lower panel). Residues 1–21 and 54–59 of Hrk_DTM
flanking the sequence of Hrk_medium (Fig. 1A) fall outside the
binding area as shown in Fig. 7A. As Hrk_DTM binds with higher
affinity than Hrk_medium, the structural model suggests that the
flanking sequences, albeit located outside the relevant interacting
region in Harakiri, could play a role in binding.
Mouse Diva and human Harakiri are better studied than their
human and mouse homologues, respectively. Thus, for practical
reasons here we have characterized the hybrid interaction between
the two proteins. The question that follows is whether binding
between the intraspecies proteins is similar. There are several facts
suggesting that the interaction will conserve the same overall
structural features. For instance, the 3D structures in Fig. 7B&C,
which correspond to human and mouse heterodimers are equivalent
at the structural level. Moreover, the hybrid model built for Diva/
Hrk_DTM is structurally compatible with them (Fig. 7). In addition,
the amino acid sequences of Hrk_DTM and Hrk_medium in human
and mouse are 75% identical, also suggesting a similar binding
behavior. Furthermore, the four conserved hydrophobic residues in
the BH3 domain known to anchor the helix to the antiapoptotic
protein groove [8] (residues T33, L37, L40 and L44 for Harakiri) are
identical both in the human and mouse species. Together, these
considerations and the observed specificity of the interaction suggest
that intraspecies protein binding between Diva and Harakiri is
analogous at the structural level.
Apparent binding affinity between Diva and Harakiri
NMR titration experiments on Diva upon binding to the
cytosolic domain of Harakiri were performed to estimate an
apparent dissociation constant of the complex (Fig. 2B). However,
we have shown that Harakiri is largely unstructured before
binding and as already established for BH3-peptides [8,9], we
propose that it adopts helical structure upon complex formation. It
has been previously reported that coupled folding-and-binding is
not realistically represented by the conventional two-state process
[31]. Therefore, in an attempt to obtain an approximate value of
the dissociation constant of the Diva/Hrk_DTM complex we have
assumed the simplest binding model that takes into account
Hrk_DTM folding/unfolding equilibrium:
Hrk DTMuzDivuHrk DTMfzDivuHrk Div
Where Hrk_DTMu and Hrk_DTMf are the unfolded and folded
forms of Hrk_DTM, respectively. Div is the unbound form of Diva
and Hrk_Div is the complex (see Materials and Methods).
The NMR titration experiments (Fig. 2B) depend on both the
dissociation constant of the complex (Kdapp) and the unfolding/
folding constant (Ku). These two processes cannot be separated in
the overall chemical shift change resulting from complex
formation. Therefore, for proper fitting of the data the Ku value
was fixed based on the structure population obtained from the CD
experiments. The values of Kdapp and Ku strongly depend on each
other thus, upper and lower limits of Kdapp can be obtained
considering two possible scenarios in the folding/unfolding
equilibrium of Hrk_DTM. On the one hand we assumed that
the observed 13% of helical population in the CD spectrum of the
59-residue long construct is localized in the critical binding region
used in the estimation of the Kdapp are boxed and the linewidth of the corresponding signals has been increased relative to the others for clarity.
Shown spectra correspond to 9 titration points out of the 16 measured at the following values of Hrk_DTM concentration (mM): 0, 0.08, 0.16, 0.29,
0.44, 0.73, 0.85, 1.60, 1.80. Some panels look particularly crowded because of the superposition of a total of 9 spectra. The noise level of the spectrum
corresponding to the titration at 1.80 mM Hrk_DTM was reduced for clarity as the threshold level had to be lowered to properly determine the
chemical shift of the significantly broaden signals. (C) Upper panel: chemical shift differences (Dd= {[Dd1H)]2+[Dd(15N)/5]2}1/2) between spectra of Diva
and a mixture of Diva (0.12 mM) and Hrk_DTM (0.85 mM) versus Diva’s residue number. Lower panel: chemical shift changes between spectra
resulting from Diva/Hrk_DTM (0.18 mM/0.37 mM) and Diva/Hrk_medium (0.1 mM/1 mM) mixtures vs. Diva’s residue number. The position of the a-
helices and the BH domains is indicated.
doi:10.1371/journal.pone.0015575.g002
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Figure 3. Interacting region mapped in the 3D structure of Diva. Comparison to other prosurvival/BH3_peptide complexes. (A) Ribbon
diagram of the 3D structure of Diva (pdb ID 2KUA) showing in orange the position of residues with chemical shift perturbations upon binding to
Hrk_DTM. Light and dark orange indicate perturbations between 0.04 and 0.1 ppm, and larger than 0.1 ppm, respectively. Helices involved in the
interaction are numbered. (B,C) Ribbon diagram of human Mcl-1/Bid_BH3 (pdb ID 2KBW) (B) and mouse Bcl-XL/Bad_BH3 (pdb ID 2BZW) (C)
complexes. The peptides are shown as translucent green cylinders. The orientation of Diva, Mcl-1 and Bcl-XL is equivalent. Helices forming the typical
binding pocket are colored in dark orange and numbered. Fig. 3A,B,C were created with PyMOL [43]. (D) Secondary structure and sequence
alignment of mouse Diva (Q9Z0F3), human Mcl-1 (Q07820), mouse Bcl-XL (Q64373) and human BFL-1 (Q16548) used in the structural studies of the
complexes with Harakiri, Bid (pdb ID 2KBW), Bad (pdb ID 2BZW) and Noxa (pdb ID 3MQP) respectively. Helices are color coded and numbered from 1
to 8. BH domains appear as bars. The amino acid sequences correspond to those of the structural studies, and thus do not show the C-terminal TM
helix. Residues involved in the interacting surface with the cytosolic domain of Harakiri and the other BH3 peptides are underlined. (E) Sequence
alignment of the cytosolic domain of Harakiri and the BH3 peptides used in the structural studies mentioned in D. The BH3 domains are colored in
blue. The conserved small residue (Ser/Gly) and Asp residue in the BH3 domain are shown in red. The four conserved hydrophobic residues in the BH3
domain of Harakiri and those known to form part of the contact area in the complexes are underlined.
doi:10.1371/journal.pone.0015575.g003
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from residues 22–53 (Hrk_meduim), which leads to a Ku value of
,3.1. By fixing this parameter, changes in the chemicals shifts of
Diva (Fig. 2B) were fitted according to the proposed model
(Materials and Methods) (Fig. 8). The obtained upper limit for the
apparent dissociation constant is Kdapp= 397672 mM. On the
other hand, by assuming that the 13% helical content is distributed
throughout the entire cytosolic domain, Ku ,6.7 and the smallest
resulting value of Kdapp is ,132 mM for V45 (Fig. 8). The upper
and lower limits of Kdapp are in the order of magnitude of the
largest dissociation constant values found for other BH3-peptide/
prosurvival protein complexes (nM to .100 mM) [9,16,17].
These results are in contrast to recent studies by isothermal
titration calorimetry on the binding capabilities of Diva to peptides
comprising the BH3 domain of several Bcl-2 proteins [22]. These
studies found that Diva does not show ‘‘substantial affinity’’ for
any BH3-derived peptide, including Bak and Harakiri. However,
previous work using co-immunoprecipitation indicates that Diva
can interact with Bak [21]. Our ELISA and NMR data also show
unambiguously that Diva interacts with Harakiri and that the
interaction is specific as binding involves a particular region in the
3D structure of Diva (Fig. 3A, D). The observed differences could
be related to the systems and conditions used in the different
experiments. Particularly, the isothermal calorimetry titrations
reached Harakiri BH3-peptide concentration of only 17.5 mM,
Figure 4. Interaction between Diva and Hrk_medium by NMR. Superposition of regions of Diva [1H-15N]-HSQC spectra resulting from the
titration with Hrk_medium. Signals of residues boxed in Fig. 2B are shown here for comparison. Spectra correspond to the following Hrk_medium
concentration values (mM): 0, 0.12, 0.5, 1.0.
doi:10.1371/journal.pone.0015575.g004
Figure 5. Circular dichroism spectra of Hrk_DTM. Far–UV CD
spectra of Hrk_DTM in the absence (white circles) and presence (black
circles) of 35% (v/v) trifluoroethanol. The percentage of a-helical
population calculated as described in Materials and Methods is 13% and
35%, respectively. The minimum of the curve at 222 nm is characteristic
of helix formation.
doi:10.1371/journal.pone.0015575.g005
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whereas the upper limit for the apparent Kd of our studies is
,400 mM. Moreover, the BH3 peptide from Harakiri used in the
isothermal titration calorimetry is 26 residues long. This is shorter
than Hrk_medium, which already shows very weak binding
relative to Hrk_DTM. Other reports have related the length of
peptides comprising Harakiri’s BH3 domain to differential binding
affinity for Bcl-2 and Bcl-XL, with longer peptides (26 vs. 20 amino
acids) showing stronger interactions [17].
The isothermal titration calorimetry results are also in contrast
with the structural similarity between Diva and other Bcl-2
proteins [22]. Mutations in Diva relative to other members of the
Bcl-2 family in two conserved residues (G88S, R89Q) of the BH1
domain that forms part of the hydrophobic cleft have been
suggested to be responsible for the non-detected binding [22]. By
contrast, our NMR data clearly show that Diva uses this
hydrophobic groove, including the BH1 domain (Fig. 2C), to
interact with Harakiri. Particularly, significant changes in the
chemical shift of S88 (Fig. 2B, Fig. 8) and Q89 (Fig. 2C) upon
the interaction with Hrk_DTM were observed, indicating that
these residues are perturbed by the interaction.
Comparison of Diva/Harakiri affinity to other
heterodimers in the Bcl-2 family
Dissociation constant values of direct interactions between
antiapoptotic Bcl-2 proteins and BH3-derived peptides measured
in vitro by fluorescence polarization have been found to correlate
with the apoptotic response [17]. Complexes with Kd in the
nanomolar range clearly show stronger killing activity than weaker
interactions [17]. However, heterodimers with affinity in the
micromolar range (.2.5 mM) are also functional [17]. For
instance, the BH3 domains of the BH3-only proteins Noxa A
and Noxa B with significant affinity (Kd ,20–30 nM) only for
antiapoptotic Mcl-1, show comparable killing activity in the
presence of Mcl-1 or Bcl-2, albeit the measured Kd for the latter is
.2.5 mM [17]. Similar results were found for the BH3 domain of
the BH3-only protein Bik, which shows equivalent killing activity
in the presence of Mcl-1 and BFL-1 although the affinity for both
antiapoptotic proteins is significantly different (Kd = 109 nM for
Mcl-1 and .2.5 mM for BFL-1) [17].
More relevant to the Diva/Harakiri complex are the results
found for the BH3 domain of Harakiri, which shows killing activity
in the presence of Bcl-2 for which the measured Kd is .2.5 mM
[17]. In addition, some discrepant results on the binding
capabilities of Harakiri for antiapoptotic Bcl-2 members have
been reported. For example, IC50 values ,50 nM, measured by
competition assays using surface plasmon resonance, have been
found for the interaction between the BH3 domain of Harakiri
and the antiapoptotic proteins Bcl-w and BFL-1 [16]. In contrast,
Kd values .2.5 mM in the direct binding affinity studies have been
reported for the same proteins [17]. These discrepancies could
result from the different techniques, conditions and systems used.
In particular, it is noteworthy that 4, out of the 9 BH3-only
proteins known, show a transmembrane domain. Specifically,
Harakiri [18] and Diva [21] have been found predominantly in the
membrane, and thus they are expected in vivo to interact while
anchored to the membrane. The differences between in vivo and in
vitro binding conditions will likely be larger for those BH3-only
members with a transmembrane domain, resulting in dissociation
constants values measured in vitro that are significantly different in
vivo. For example, higher protein local concentration at the
membrane surface and restricted mobility resulting from membrane
anchoring could increase binding affinity. Therefore, the Kdapp
value reported above for the Diva/Harakiri heterodimer is only a
rough estimate of the ‘‘real’’ dissociation constant between these
proteins, which most likely decreases under in vivo conditions.
Discussion
The ELISA and NMR data herein reported consistently
demonstrate that the Bcl-2 members Diva and Harakiri are able
Figure 6. Changes in the NMR spectra of Hrk_DTM resulting
from the interaction with Diva. 1Hamide-
1Haliphatic region of TOCSY
spectra of Hrk_DTM (black) and Hrk_DTM/Diva mixture (0.85 mM/
0.12 mM) (red). The small dispersion in 1H amide chemical shifts, the
absence of signals for methyl groups close to 0 ppm and the severe
signal overlap are characteristic of disordered proteins. Changes in the
chemical shifts of Hrk_DTM upon the addition of Diva likely result from
an overall structural rearrangement toward the helical conformation in
addition to the interaction with Diva. Signals in the [1H-1H]-TOCSY
spectrum of the mixture are observed only for Hrk_DTM because of the
low concentration of Diva relative to Hrk_DTM and Diva’s broader
signals, most likely at the noise level according to its larger molecular
weight (,18 kDa for Diva, ,6 kDa for Hrk_DTM).
doi:10.1371/journal.pone.0015575.g006
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to interact in vitro. Moreover, the NMR results indicate that the
interaction is specific involving in Diva the same hydrophobic cleft
observed in all of the reported 3D structures of other Bcl-2
complexes. No information on the interaction between Diva and
Harakiri has been previously reported. Thus, further studies are
necessary to test whether the Diva/Harakiri complex is function-
ally relevant in apoptosis. Nevertheless, from the biophysical and
structural perspective our results indicate that Diva is structurally
suited to function as other negative regulators of cell death, in
contrast to recent binding studies suggesting that the structure of
Diva reveals a functionally divergent protein [22].
In addition, we show that the full-length cytosolic domain of
Harakiri is intrinsically disordered with residual a-helical struc-
ture. Therefore, we propose that Harakiri folds as an a-helix upon
complex formation, as previously suggested for the interaction
between the BH3-only member Bim and the antiapoptotic protein
Bcl-w [10]. Our data also indicate that the cytosolic domain of
Harakiri binds Diva with higher affinity than the shorter
constructs. However, Diva shows the same interacting surface
for both Hrk_DTM and Hrk_medium, suggesting that factors
other than those pertinent to intermolecular interactions within
the interacting area are playing a role in binding. The influence on
binding of disordered regions outside the interacting interface has
been theoretically predicted [32] and experimentally observed
before [33]. Intrinsically disordered proteins can follow different
binding mechanisms in which preformed elements of secondary
structure, together with concomitant folding and flexibility in the
unbound and bound state can play important roles [34]. Thus,
further mechanistic studies are necessary to identify the factors
responsible for the affinity differences of the Harakiri constructs.
Nevertheless, our results suggest that studies on fragments longer
than the typically 25-residue BH3 peptides will help to better
understand Bcl-2 interactions.
Materials and Methods
Protein production
The c-DNA fragment encoding for residues 1–160 of mouse
Diva (lacking its putative 30-residue long transmembrane a-helix)
was cloned into the NcoI and HindIII restriction sites of pBAT4
expression vector [35], which was transformed in BL21(DE3) E.
Coli strain (Novagen). Bacteria were grown at 37uC and protein
expression was induced at OD600 of 0.6–0.7 for 6 h at 30uC by
adding 1 mM IPTG (isopropyl-b-D-thiogalacto-pyranoside). Uni-
formly 15N- and 13C-labeled Diva was produced using 13C6-D-
glucose and 15NH4Cl (Spectra Stable Isotopes) as sole carbon and
nitrogen sources, respectively. The cells were harvested by
centrifugation and resuspended in a buffer containing 50 mM
sodium acetate at pH 5.4, 50 mM NaCl, 0.1 mM protease
inhibitor cocktail (Sigma) and 1 mM TCEP (Tris(2-carboxyethyl)-
phosphine). Cells were lysed by sonication at 4uC and centrifuged
at 25000 rpm for 30 minutes. The soluble protein was purified by
cation exchange chromatography using an SP sepharose Fast Flow
column (GE Healthcare). A second purification step was necessary
using reverse phase chromatography in water-acetonitrile mix-
tures, followed by lyophilization of the protein solution.
Peptide synthesis
The full-length cytosolic domain of human Harakiri, residues
1_59 (Hrk_DTM), and fragments 22–53 (Hrk_medium) and 33–
47 (Hrk_BH3) were synthesized and purified by CASLO
Laboratory (Denmark). The purity (.95%) and molecular weight
were confirmed by liquid chromatography and mass spectrometry,
respectively. Hrk_medium and Hrk_BH3 are protected by a C-
terminal amide.
Enzyme-linked immunosorbent assays (ELISA)
Microplates (Costar Ltd., US) were coated with 50 ml of Diva in
PBS at a concentration of 7.5 mg/ml. After overnight incubation
at 4uC plates were washed three times with distilled water and then
blocked with 2.5% BSA (Sigma-Aldrich, Spain) in PBS for 2 h at
37uC. Solutions of Harakiri fragments were prepared at fixed
initial peptide concentrations (derived from absorbance measure-
ments) containing PBS, 2.5% BSA and 0.1% Tween to avoid
aggregation and non-specific binding. Samples were loaded and
incubated overnight at 4uC. BSA at 2.5% in PBS was used as
negative control. After thorough wash (6 times) with distilled water
and 0.1% Tween, bound Harakiri fragments were detected by a
polyclonal rabbit anti-Harakiri BH3 domain antiserum (1:1000)
(Abcam, UK). Following a streptavidin peroxidase conjugate anti-
rabbit Ig (1:1000) (Dako) as secondary antibody, the peroxidase
activity was detected by the addition of 3,39,5,59-tetramethylben-
Figure 7. 3D model of the Diva/Harakiri heterodimer compared to other prosurvival/BH3_peptide complexes. (A,B,C) Surface and
ribbon representation of the Diva/Hrk_DTM heterodimer (A), Mcl-1/Bid_BH3 (pdb ID 2KBW) (B) and Bcl-XL/Bad_BH3 (pdb ID 2BZW) (C) complexes. The
interacting surface in Diva and the other prosurvival proteins is colored in orange. The BH3-only protein fragments are shown as green ribbons and
the N-termini are indicated. Residues Arg 22, Ala 54 and Ala 59 in Hrk_DTM are indicated to show that the N and C-terminal regions of the cytosolic
domain of Harakiri are outside the critical binding region. The orientation of the three complexes is equivalent. Fig. 7 was created with MOLMOL [42].
doi:10.1371/journal.pone.0015575.g007
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zidine dihydrochloride peroxidase substrate (Sigma). Colour
development was then allowed to proceed for 15 min at room
temperature and stopped adding 0.1 M H2SO4. The optical
density was read at 450 nm on an ELISA plate reader (Labsystems
Multiskan BICHROMATIC). All assays were done in duplicate.
The absorbance of the control is within typical background values
in ELISA experiments indicating close to optimum conditions for
binding level detection.
NMR experiments
NMR samples were prepared at 0.1–0.22 mM 13C,15N-labeled
Diva in 10% 2H2O/H2O containing 20 mM deuterium-enriched
sodium acetate buffer at pH 5.4, 5 mM 2H15-TCEP and 0.1 mM
NaN3. NMR data were acquired at 35uC on a Bruker Avance III
600 MHz spectrometer with a triple resonance tri-axial gradient
probe. Amide 1H-15N chemical shifts were obtained using
[1H-15N]-HSQC experiments [25] that were processed with
NMRPipe [36] and analyzed with PIPP [37]. Diva samples were
titrated with stock solutions of unlabeled Hrk_DTM, Hrk_medium
and Hrk_BH3 in the same buffer used for Diva. Protein and
peptide concentrations were derived from absorbance measure-
ments. For each titration point [1H-15N]-HSQC experiments were
acquired to monitor chemical shifts changes in Diva upon Harakiri
fragment addition. [1H-1H]-TOCSY experiments on Hrk_DTM
in the presence and absence of Diva were acquired with a mixing
time of 80 ms. Hrk_DTM is in molar excess relative to Diva in the
mixture (0.85 mM/0.12 mM, Hrk_DTM/Diva) for the observa-
tion in the [1H-1H]-TOCSY spectrum of signals from Hrk_DTM
alone.
Circular dichroism experiments
Hrk_DTM was dissolved in 20 mM sodium phosphate buffer at
pH 5.8 in the presence and absence of 35% (v/v) trifluoroethanol
(TFE). The concentration of Hrk_DTM was 23 mM in the buffer
without TFE and 44 mM in TFE. The concentration was
calculated by measuring absorbance at 280 nm. CD measure-
ments were acquired at room temperature using a JASCO model
J-815 spectropolarimeter with a 1 mm cuvette. The CD signal at
222 nm was converted to mean residue ellipticity ([h]obs) after
subtracting the blank using the equation:
½hobs~100½h222=cNl ð1Þ
where c is the peptide concentration (in mM), N is the number of
peptide residues and l is the path-length (in cm).
The percentage of a-helical population was determined using
the following equation:
%helix~(½hobs-½hcoil)=(½hhelix-½hcoil) ð2Þ
where [h]helix is the mean residue ellipticity of a complete helix,
i.e., -42,500(1-(3/N)), and [h]coil is the ellipticity of a random coil,
i.e. +640 [38,39].
Apparent dissociation constant measurement
Exchange between the free and bound forms of Diva is fast on
the NMR time scale and thus the observed chemical shifts (d) are
weight-averaged relative to the free and bound fractions:
d~FbdD HzFf dD ð3Þ
Where Fb is the fraction of bound Diva, Ff is the fraction of free
Diva, dD_H is the chemical shift of Diva bound to Hrk_DTM and
dD is the chemical shift of free Diva. Since Fb+Ff= 1, equation (3)
becomes;
Fb~½Hrk Div=½DivT ~(d-dD)=(dD H-dD) ð4Þ
where [Hrk_Div] and [DivT] are the concentration of Diva bound
to Hrk_DTM and the total concentration of Diva, respectively.
(dD_H - dD) is the chemical shift change at infinite concentration of
Hrk_DTM.
Previously reported studies on coupled folding and binding have
shown that the binding process might no be adequately
represented by two states [31]. Therefore, for a more realistic
description of the binding of Hrk_DTM to Diva taking into
account that Hrk_DTM is largely unstructured in the unbound
form and likely folds upon binding, we have assumed the simplest
Figure 8. Determination of the apparent dissociation constant
of the Diva/Harakiri complex. Chemical shift changes of signals in
the [1H-15N]-HSQC spectra of Diva shown in Fig. 2B vs. the total
concentration of Hrk_DTM (black circles). Fittings of the experimental
data to equation (11) (Materials and Methods) are shown with a
continuous line. The corresponding residues and individually measured
Kdapp values are indicated. The concentration of Hrk_DTM (mM) for
each point is: 0, 0.04, 0.08, 0.12, 0.16, 0.24, 0.29, 0.37, 0.44, 0.61, 0.73,
0.81, 0.85, 1.30, 1.60, 1.80. Diva’s NMR signals undergo significant
broadening for the last three titration points at the largest Hrk_DTM
concentration, and thus the error in chemical shift determination for
these points is likely larger.
doi:10.1371/journal.pone.0015575.g008
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model in which Hrk_DTM folding/unfolding equilibrium is
related to binding as follows:
Hrk DTMuzDivuHrk DTMfzDivuHrk Div ð5Þ
where Hrk_DTMu and Hrk_DTMf are the unfolded and folded
forms of Hrk_DTM, respectively. Div is the unbound form of Diva
and Hrk_Div is the complex.
The equilibrium constants of the model shown in equation (5)
are:
Ku~½Hrk DTMu=½Hrk DTMf  ð6Þ
Kbapp~½Hrk Div=½Hrk DTMf ½Div ð7Þ
Ku and Kbapp are the unfolding and apparent binding constants,
respectively.
In addition, the total concentration of Diva and Hrk_DTM are:
½DivT ~½Divz½Hrk Div ð8Þ
½Hrk DTMT ~½Hrk DTMuz½Hrk DTMf z½Hrk Div ð9Þ
where [DivT] and [Hrk_DTMT] are the total concentration of
Diva and Hrk_DTM at each titration point. Substituting equation
(9) in (6):
½Hrk DTMf ~ ½Hrk DTMT {½Hrk Divð Þ= Kuz1ð Þ ð10Þ
Substituting equations (4), (8) and (10) in equation (7):
(d-dD)~
Kbapp
½Hrk DTMT (dD H-dD)-½DivT (d-dD)
Kuz1
 
1zKbapp
½Hrk DTMT {(½DivT (d-dD)=(dD H-dD))
Kuz1
 
ð11Þ
There are three unknowns in equation (11), i.e., (dD_H - dD),
Kbapp and Ku. To fit the data properly we fixed the value of Ku,
which can be estimated from the CD experiments (Fig. 5). Upper
and lower limits of Ku depend on the number of residues assumed
to adopt the helical conformation and derive in upper and lower
limits for Kbapp. For the Ku lower limit it was assumed that the
helical population is localized in the critical binding region in
Harakiri (residues 22–53). Thus, out of the 59 residues in
Hrk_DTM, the 32 residues of Hrk_medium shown to be sufficient
for the interaction fold into an a-helix. This assumption leads to
folded and unfolded populations of 24% and 76%, respectively,
and thus Ku ,3.1. By fixing this parameter the changes in
chemical shift resulting from the titration of the total of 10 signals
shown in Fig. 2B were fitted to equation (11) using the software
GRACE (http://plasma-gate.weizmann.ac.il/Grace). The indi-
vidual fits and calculated Kdapp are shown in Fig. 8. A global
upper limit for Kdapp is obtained from the average of the 10 values
(397672 mM). For the Ku upper limit it was assumed that all
residues populate the helical conformation. Thus, the folded and
unfolded populations are 13% and 87%, respectively and Ku is
,6.7. Fixing this parameter the lowest Kdapp value is 132 mM for
V45.
Molecular docking calculations of Diva/Harakiri complex
The program I-TASSER (Protein structure and function
prediction based on iterative TASSER simulations) [40] was used
to produce a 3D model of Hrk_DTM (59 residues). For a better
representation of Hrk_DTM, the structure of the longest (35
residues) reported a-helical peptide comprising the BH3 region of
a BH3-only protein (Bid) complexed to a prosurvival Bcl-2 protein
(Mcl-1) [28] was used as template. The five predicted structures
with the highest scores consistently show an a-helix spanning
Harakiri residues 23 to 57. In contrast, loops of different lengths
are predicted from residues 1 to 22. Molecular docking was carried
out with the software HADDOCK (High Ambiguity Driven
biomolecular DOCKing based on biochemical and/or biophysical
information) [41] using the 3D structure of Diva [22] and the
structure of Hrk_DTM with the highest score from I-TASSER.
The online HADDOCK server was used to build a model of the
Diva/Hrk_DTM heterodimer. HADDOCK uses residues in-
volved in the interaction (so-called ‘‘active’’ residues) to create a
list of ambiguous interaction restraints used in the docking
calculation. These restraints set intermolecular interatom upper
distance limits of 2 A˚ for all atoms of residues input as ‘‘active’’.
‘‘Passive’’ residues, which do not directly participate in the
interaction and surround active ones, can also be incorporated.
Residues in helices 2, 3, 4, 5 and 8 with chemical shift
perturbations larger than 0.05 ppm and with .20% of the total
surface solvent exposed were included as ‘‘active’’ for the
molecular docking. No ‘‘passive’’ residues were defined. Solvent
accessibility was calculated with MOLMOL [42]. The list of
‘‘active’’ residues used and the corresponding percentage of
solvent accessible surface is: R43 (33%), R47 (36%), Q48 (26%),
Q51 (38%), H53 (24%), E55 (37%), F56 (42%), S59 (27%), S63
(25%), R64 (51%), K77 (47%), S88 (23%), D152 (37%), R156
(50%), F157 (34%), K159 (53%). For HrK_DTM, residues from
22–53 known to be critical for the interaction from the NMR and
ELISA data were included as ‘‘active’’ residues. No ‘‘passive’’
residues were defined. HADDOCK default parameters were
accepted for the docking protocol. No other restraints were
incorporated by the user besides the residues specified above. The
three resulting HADDOCK clusters of structures with highest
scores out of 1000 calculated were inspected and compared to
known antiapoptotic protein/BH3-peptide 3D complexes. The
relative orientation of both molecules in the best structure of
cluster 3 is closer to other known complexes and thus was selected
as the representative structure.
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